Polyethylene Glycol in Constipation-Predominant Irritable Bowel Syndrome

被引：4
|
作者：
Shearer, Jessica [1 ]
Ford, Alexander C. [1 ,2 ]
机构：
[1] St James Univ Hosp, Leeds Gastroenterol Inst, Leeds LS9 7TF, W Yorkshire, England
[2] Univ Leeds, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2014年 / 109卷 / 01期
关键词：
PLACEBO-CONTROLLED TRIAL; LINACLOTIDE; EVALUATE; EFFICACY; SAFETY;
D O I：
10.1038/ajg.2013.389
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：135 / 135
页数：1
相关论文
共 50 条
  • [41] Abnormal colonic propagated activity in patients with slow transit constipation and constipation-predominant irritable bowel syndrome
    Bassotti, G
    Chistolini, F
    Marinozzi, G
    Morelli, A
    [J]. DIGESTION, 2003, 68 (04) : 178 - 183
  • [42] Comparison of colonic transit time between patients with constipation-predominant irritable bowel syndrome and functional constipation
    Ansari R.
    Sohrabi S.
    Ghanaie O.
    Amjadi H.
    Merat S.
    Vahedi H.
    Khatibian M.
    [J]. Indian Journal of Gastroenterology, 2010, 29 (2) : 66 - 68
  • [43] Editorial: differentiating chronic idiopathic constipation from constipation-predominant irritable bowel syndrome - possible and important?
    Quigley, Eamonn M. M.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (12) : 1299 - 1299
  • [44] Diarrhea-Predominant and Constipation-Predominant Irritable Bowel Syndrome: Current Prescription Drug Treatment Options
    Wechsler, Emily V.
    Shah, Eric D.
    [J]. DRUGS, 2021, 81 (17) : 1953 - 1968
  • [45] Fecal Microbiota Characteristics in Constipation-Predominant and Mixed-Type Irritable Bowel Syndrome
    Gryaznova, Mariya
    Smirnova, Yuliya
    Burakova, Inna
    Morozova, Polina
    Lagutina, Svetlana
    Chizhkov, Pavel
    Korneeva, Olga
    Syromyatnikov, Mikhail
    [J]. MICROORGANISMS, 2024, 12 (07)
  • [46] Long-term safety of tegaserod in patients with constipation-predominant irritable bowel syndrome
    Tougas, G
    Snape, WJ
    Otten, MH
    Earnest, DL
    Langaker, KE
    Pruitt, RE
    Pecher, E
    Nault, B
    Rojavin, MA
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (10) : 1701 - 1708
  • [47] Update: A 54-year-old woman with constipation-predominant irritable bowel syndrome
    Farag, Nadine
    Reynolds, Eileen
    Lembo, Anthony
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (01): : 88 - 88
  • [48] Linaclotide in constipation-predominant irritable bowel syndrome and chronic idiopathic constipation: a profile of its use in the USA
    McKeage K.
    Lyseng-Williamson K.A.
    [J]. Drugs & Therapy Perspectives, 2017, 33 (11) : 497 - 504
  • [49] Functional Constipation and Constipation-Predominant Irritable Bowel Syndrome in the General Population: Data from the GECCO Study
    Enck, Paul
    Leinert, Johannes
    Smid, Menno
    Koehler, Thorsten
    Schwille-Kiuntke, Juliane
    [J]. GASTROENTEROLOGY RESEARCH AND PRACTICE, 2016, 2016
  • [50] Diarrhea-Predominant and Constipation-Predominant Irritable Bowel Syndrome: Current Prescription Drug Treatment Options
    Emily V. Wechsler
    Eric D. Shah
    [J]. Drugs, 2021, 81 : 1953 - 1968
12345